Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Useful Bacteria Need Protection


New forms of drugs for dysbacteriosis and other gastrointestinal disturbances are being developed by the Novosibirsk researchers with support of the International Science and Technology Center (ISTC).

A lot of Russians suffer from malfunction of gastrointestinal tract. The frequent reason for that is dysbacteriosis – disturbances of normal intestinal flora. To fight dysbacteriosis, physicians prescribe eubiotic drugs to patients, which contain bacteria necessary for digestion, for example, bifidumbacterin, lactobacterin, colibacterin, bificol, etc. The drugs are good, but upon intake they are destroyed in the stomach, due to that their efficiency reduces. To increase efficiency of eubiotics, they should be protected in some way.

This problem is being solved by the researchers of the State Research Center for Virology and Biotechnology “Vector” (“Vector-BiAlgam” close corporation (Koltsovo, Novosibirsk Region)) with support of the International Science and Technology Center (ISTC). Bacteria making part of the drugs need protection, and there are two main methods to defend them. The bacteria are either placed into a capsule – this is a capsulated form of drug, or they are placed on a special carrier - sorbent – this is an immobilized form.

The Novosibirsk researchers are developing and testing immobilized eubiotics. In this medication, cells of useful bacteria are placed on porous microcarrier SUMS-1 – aluminium oxide powder, the size of microparticles varying from 40 to 100 mkm, the surface of microparticles being covered by carbon (which is used in medicine as enterosorbent). Adsorption occurs on the carrier owing to both physical and chemical mechanisms. Proteins of the cellular wall of bacteria form chelates with the SUMS-1 surface, where magnesium serves as a complexing agent (chelation). In this case, active groups of bacteria’s proteins and lipoproteids turn out to be protected from the stomach’s aggressive acid medium. In the meantime, unprotected bifido- and lactobacteria lose more than 90 percent of their activity in the stomach, the immobilized ones go lossless through the stomach.

Chelates are known for their stability being dependent on the medium. As the stomach has acid medium, bacteria remains in it bound with sorbent. When the drug gets into lower parts of thin bowels, the chelate disintegrates due to increased. This is what is needed, because it is particularly in the thin bowels and than in the thick bowels that bifido- and lactobacteria get released from the carrier and start working. The released sorbent surface takes away toxins and metabolic products. SUMS-1 is a very efficient enterosorbent: it does not sorb small molecules - acids, carbohydrates, trace elements and it does not sorb large mass proteins either – transport proteins and enzymes. That is why the water-salt balance is not broken and bowel’ enzymatic activity does not decrease. Along with that, SUMS-1 actively binds proteins of medium mass, where toxins and products of uncomplete metabolism belong to. They are brought out of the organism together with the sorbent.

The Novosibirsk researchers have created complex eubiotic based on the SUMS-1sorbent, which includes consortium of several species of the most active cultures of bifido- and lactobacteria. These bacteria suppress reproduction of pathogenic, saprogenous and gas-producing microflora, they participate in peptic processes and synthesis of vitamins, in metabolism of trace elements and biologically active substances. On top of that, bifido- and lactobacteria act as immunostimulants.

New drugs underwent investigation at all levels. Testing them on laboratory animals, the researchers have made sure that they are non-toxic, do not cause side effects and at the same time destroy harmful intestinal flora and increase vital capacity of the organism. While clinical trials of the complex immobilized eubiotic are being prepared, the Novosibirsk State Medical Academy (based on the clinic) has already carried out clinical trials of its analogue called “Ecoflor”, which belongs to the category of bioactive nutritional supplements. 70 patients who were taking “Ecoflor” within two weeks have improved digestion and general habitus, and the gut organisms have become normal. The complex eubiotic production is still limited to pilot batches, and its analogue “Ecoflor” is already produced as a bioactive nutritional supplement.

And finally, it should be pointed out where new eubiotic drugs will be applied. They will be used not only for dysbacteriosis but also for toxin poisoning, enteric infection, pancreatitis, gastritis, ulcer and other chronic ailments, allergy, radiolesion and even tuberculosis and oncology treatment.

Sergey Komarov | alfa
Further information:

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>